Skip to main content
. 2012 Oct 23;7(1):121–129. doi: 10.1016/j.molonc.2012.10.001

Figure 5.

Figure 5

Working model for LPA‐induced EGFR transactivation inhibited by resveratrol. LPA activates EGFR through Gi and G13 subsequently induces Ras/Rho/ROCK activation, leading to lineage‐specific proteolytic enzyme expression. Resveratrol and gefitinib inhibit LPA‐ and EGF‐induced EGFR activation, proteolytic enzyme secretion and ovarian cancer cell progression.